Kate Roberts

849 total citations
19 papers, 633 citations indexed

About

Kate Roberts is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Kate Roberts has authored 19 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Kate Roberts's work include Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Estrogen and related hormone effects (4 papers). Kate Roberts is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Estrogen and related hormone effects (4 papers). Kate Roberts collaborates with scholars based in Australia, United Kingdom and United States. Kate Roberts's co-authors include Robert Wilson, Peter R. Preiser, Malcolm Strath, Paul W. Denny, Donald H. Williamson, K. Rangachari, Anjana Roy, Kirsty Rickett, Natasha Woodward and Kenneth J. O’Byrne and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Molecular Biology and Cochrane Database of Systematic Reviews.

In The Last Decade

Kate Roberts

17 papers receiving 615 citations

Peers

Kate Roberts

PHEOH

PARAS

ONCOL

ECOLO

Wiboonchai Yutanawiboonchai Thailand

Carsten R. Lincke Netherlands

Donatella Giovannini France

Siddhartha Das United States

Srikanth Santhanam India

M. F. Tam Taiwan

Meiji Arai Japan

Min Ji Seo South Korea

Slavica Pavlovic‐Djuranovic Germany

Melissa D. Docampo United States

Wiboonchai Yutanawiboonchai Thailand

Kate Roberts

233 ×0.8

99 ×0.6

PHEOH

325 ×2.3

PARAS

89 ×0.6

ONCOL

157 ×1.7

ECOLO

Citations per year, relative to Kate Roberts Kate Roberts (= 1×) peers Wiboonchai Yutanawiboonchai

Countries citing papers authored by Kate Roberts

Since Specialization

Citations

This map shows the geographic impact of Kate Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Roberts more than expected).

Fields of papers citing papers by Kate Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Roberts. The network helps show where Kate Roberts may publish in the future.

Co-authorship network of co-authors of Kate Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Roberts. A scholar is included among the top collaborators of Kate Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Roberts. Kate Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Roberts, Kate, et al.. (2020). Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Systematic Reviews. 2020(1). CD012988–CD012988. 41 indexed citations

Ladwa, Rahul, et al.. (2020). Computed Tomography Texture Analysis of Response to Second-Line Nivolumab in Metastatic Non-Small Cell Lung Cancer. PubMed. 9(3). LMT38–LMT38. 12 indexed citations

Roberts, Kate, Robert M. Mason, Rahul Ladwa, et al.. (2019). P1.01-119 Modified Lung Immune Prognostic Index (mLIPI) as a Predictive Tool of Nivolumab Outcomes in Advanced NSCLC Patients. Journal of Thoracic Oncology. 14(10). S408–S409. 7 indexed citations

Shanker, Mihir, Kate Roberts, Robert M. Mason, et al.. (2019). Prior or concurrent radiotherapy and nivolumab immunotherapy in non–small cell lung cancer. Asia-Pacific Journal of Clinical Oncology. 16(1). 56–62. 17 indexed citations

O’Byrne, Kenneth J., et al.. (2019). Modified Lung Immune Predictive Index (mLIPI) as a predictive tool of nivolumab outcomes and immune related adverse events in advanced non-small cell lung cancer (NSCLC) patients. Lung Cancer. 127. S67–S68. 4 indexed citations

Roberts, Kate, et al.. (2018). P3.01-74 Clinical and Radiological Predictors of Efficacy to Nivolumab in NSCLC: A Multi-Institutional, Retrospective Cohort Study.. Journal of Thoracic Oncology. 13(10). S895–S895. 1 indexed citations

Roberts, Kate, Robert M. Mason, Brett Hughes, et al.. (2018). Prior or concurrent radiotherapy and nivolumab immunotherapy in non-small cell lung cancer. Annals of Oncology. 29. viii533–viii533. 2 indexed citations

Ladwa, Rahul, Kate Roberts, Kenneth J. O’Byrne, & Kenneth A. Miles. (2018). Quantitative CT texture assessment of tumour heterogeneity to predict those patients with non-small cell lung cancer most likely to benefit from immune checkpoint inhibitors.. Journal of Clinical Oncology. 36(15_suppl). e21027–e21027. 2 indexed citations

Roberts, Kate, Kirsty Rickett, Dimitrios Vagenas, & Natasha Woodward. (2018). Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Systematic Reviews. 5 indexed citations

10.

Roberts, Kate, Robert M. Mason, Jun Hee Hong, et al.. (2018). Immune-related adverse events and nivolumab outcomes in non-small cell lung cancer patients: A multi-institutional, retrospective cohort study.. Journal of Clinical Oncology. 36(15_suppl). 9067–9067. 7 indexed citations

11.

Roberts, Kate, Kirsty Rickett, Mark D. Chatfield, & Natasha Woodward. (2018). Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Systematic Reviews. 1 indexed citations

12.

Roberts, Kate, Kirsty Rickett, Ristan M. Greer, & Natasha Woodward. (2017). Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 111. 66–80. 41 indexed citations

13.

Roberts, Kate, et al.. (2017). Management and Survival of Patients with Leptomeningeal Disease from Breast Cancer: A Case Series. Griffith Research Online (Griffith University, Queensland, Australia). 6(1). 17–22.

14.

Roberts, Kate, et al.. (2017). Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities. Asia-Pacific Journal of Clinical Oncology. 13(4). 277–288. 35 indexed citations

15.

Roberts, Kate, et al.. (2017). P2.07-032 Outcomes of Nivolumab in Metastatic NSCLC Patients via the Access Program Across Multiple Tertiary Oncology Centres. Journal of Thoracic Oncology. 12(11). S2427–S2428. 1 indexed citations

16.

Roberts, Kate, et al.. (2017). P2.07-033 Anti-PD1-Induced Rotator Cuff Injury: A Case Series. Journal of Thoracic Oncology. 12(11). S2428–S2428.

17.

Hill, Nicholas S., Ioana R. Preston, & Kate Roberts. (2008). Patients with Pulmonary Arterial Hypertension in Clinical Trials: Who Are They?. Proceedings of the American Thoracic Society. 5(5). 603–609. 12 indexed citations

18.

Wilson, Robert, Paul W. Denny, Peter R. Preiser, et al.. (1996). Complete Gene Map of the Plastid-like DNA of the Malaria ParasitePlasmodium falciparum. Journal of Molecular Biology. 261(2). 155–172. 439 indexed citations

19.

Roberts, Kate. (1952). Effects of Cortisone on Electrocardiographic Changes in Adrenal Insufficiency.. Experimental Biology and Medicine. 79(1). 32–34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact